http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1334705-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-10
filingDate 1970-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1973-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1334705-A
titleOfInvention Pharmaceutical compositions containing kynurenic acid derivatives
abstract 1334705 Derivatives of 4-oxo-1,4-dihydroquinoline-2-carboxylic acid IMPERIAL CHEMICAL INDUSTRIES Ltd 19 May 1971 [19 June 1970] 29905/70 Heading C2C [Also in Division A5] The invention comprises (with numerous exceptions) compounds of formula wherein R<SP>1</SP> is H, Me or Et, R<SP>2</SP> is OH or C 1-6 alkoxy, and ring A may be substituted by 1 or 2 of C 1-5 alkyl and alkoxy, benzyl, benzyloxy, acetyl, halogen, CF 3 , NO 2 or NH 2 , or it may be fused with a 5,6- or 7,8-benzene ring, a methoxysubstituted benzene ring, or with (CH 2 ) 4 ; and their non-toxic pharmaceutically acceptable salts. In examples, the acids are prepared by hydrolysing the esters, which are in turn made by reacting a correspondingly substituted aniline with an ester of oxaloacetic or acetylenedicarboxylic acid, and heating the ester of 1-phenylaminoethylene-1,2-dicarboxylic acid so formed; exceptionally, an ester of the above formula containing an NH 2 substitute is prepared by reducing the corresponding nitrocompound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8361734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010128345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6861424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4273930-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1851739-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7084142-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4128649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7176207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5204329-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4963566-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5270309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4476132-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6995156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0303387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0062001-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0339485-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0062001-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7026323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4281131-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1851739-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8697674-B2
priorityDate 1970-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410112156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414389442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 43.